Adam V. Weizman

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis

Joseph D. Feuerstein, Kim L. Isaacs, Yecheskel Schneider et al. · Gastroenterology · 2020 · 699 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +9

Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease

Adam V. Weizman, Eun Jin Ahn, Reka Thanabalan et al. · Alimentary Pharmacology & Therapeutics · 2011 · 114 citations · Full text

Social Sciences, Pharmacotherapy, Clinical Pharmacology +10

The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn’s and Colitis Canada

Eric I. Benchimol, Çharles N. Bernstein, Alain Bitton et al. · Journal of the Canadian Association of Gastroenterology · 2018 · 75 citations · Full text

Medicine, Chronic Disease Control, Health Policy +10

Clinical, Serologic, and Genetic Factors Associated with Pyoderma Gangrenosum and Erythema Nodosum in Inflammatory Bowel Disease Patients

Adam V. Weizman, Brian Huang, Dror Berel et al. · Inflammatory Bowel Diseases · 2014 · 73 citations · Full text

Medicine, Dermatology, Immunology +17

Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease

Sayam Dubash, Thiraupathy Marianayagam, Ilaria Tinazzi et al. · Lara D. Veeken · 2018 · 70 citations · Full text

Medicine, Clinical Sciences, Pathology +12